Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil treatment can stimulate hair growth in hairless puppies if applied early.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The E2 protein affects gene activity in hair follicles of mice.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Erdr1 could be a new marker for diagnosing hair loss.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

Onions may help reduce cancer risk and obesity-related issues.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

A new technology showed that the SOX9 gene might control heart scar formation after injury, suggesting new treatment possibilities.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Certain genes may promote longer root hairs in plants when phosphorus is low.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

An 8-year-old girl has a rare genetic disorder causing complete, irreversible hair loss and skin bumps.

Oral processed egg yolk improves hair regrowth and quality in alopecia patients.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Some treatments can improve skin's defense against damage, but overuse may cause other skin problems.

Nrf2 helps protect skin from damage but too much can cause skin problems.

The study suggests that higher levels of SIRT1 and SIRT2 may improve overall cell health and aging processes.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.